Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Interdos Pharma is a specialty pharmaceutical company based in Oss, Netherlands, that focuses on the development and manufacturing of advanced drug delivery systems. The company is a recognized leader in controlled-release technology, specifically utilizing polymer-based platforms for vaginal rings and long-acting implants. Interdos provides a comprehensive suite of services ranging from early-stage formulation and analytical development to clinical trial supply and full-scale commercial manufacturing. Their primary therapeutic focus is within women's health, where they have successfully developed products for contraception and hormone replacement therapy. A notable achievement is the development of the Ornibel contraceptive ring, which demonstrates their expertise in hot-melt extrusion and complex hormonal formulations. The company operates out of a GMP-certified facility equipped to handle highly potent active pharmaceutical ingredients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Interdos Pharma.